Chronic myeloid leukemia in the tyrosine kinase inhibitor era: What is the best therapy?

Alfonso Quintás-Cardama, Jorge Cortes

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Chronic myeloid leukemia in the tyrosine kinase inhibitor era: What is the best therapy?'. Together they form a unique fingerprint.

Medicine & Life Sciences